Veterinary Medicines

Nobilis EDS Emulsie voor injectie

Not authorised
  • Eggdrop syndrome-1976 virus, strain BC14, Inactivated
Download as PDF

Product identification

Medicine name:
Nobilis EDS Emulsie voor injectie
Nobilis EDS Emulsion injectable
Nobilis EDS Emulsion zur Injektion
Active substance:
  • Eggdrop syndrome-1976 virus, strain BC14, Inactivated
Target species:
  • Chicken (pullet future breeder)
  • Chicken (pullet for egg production, future layer)
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Eggdrop syndrome-1976 virus, strain BC14, Inactivated
    6.50
    log2 haemagglutination inhibiting unit(s)
    /
    0.50
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken (pullet future breeder)
      • Meat and offal
        0
        day
      • Egg
        0
        day
    • Chicken (pullet for egg production, future layer)
      • Meat and offal
        0
        day
      • Eggs
        0
        day
  • Subcutaneous use
    • Chicken (pullet for egg production, future layer)
      • Meat and offal
        0
        day
      • Egg
        0
        day
    • Chicken (pullet future breeder)
      • Meat and offal
        0
        day
      • Eggs
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA05
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Belgium
Package description:
  • Nobilis EDS 500 ml PET Bottle Emulsion for injection
  • Nobilis EDS 250 ml PET Bottle Emulsion for injection
  • Nobilis EDS 500 ml glass Bottle Emulsion for injection
  • Nobilis EDS 250 ml glass Bottle Emulsion for injection

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download
German (PDF)
Published on: 22/03/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."